BL
CL icon

Balentine LLC’s Colgate-Palmolive CL Stock Holding History

Balentine LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,865
Closed -$1.34M – 253
2024
Q1 		$1.34M Sell
14,865
-843
-5% -$71.4K 0.04% 144
2023
Q4 		$1.25M Buy
15,708
+4,128
+36% +$310K 0.04% 142
2023
Q3 		$823K Sell
11,580
-1,738
-13% -$130K 0.03% 183
2023
Q2 		$1.03M Buy
13,318
+4,278
+47% +$331K 0.03% 151
2023
Q1 		$679K Sell
9,040
-14,608
-62% -$1.09M 0.02% 258
2022
Q4 		$1.86M Buy
23,648
+279
+1% +$20.9K 0.07% 112
2022
Q3 		$1.64M Buy
23,369
+8,085
+53% +$634K 0.06% 101
2022
Q2 		$1.23M Buy
15,284
+4,639
+44% +$363K 0.04% 172
2022
Q1 		$807K Buy
10,645
+8,090
+317% +$641K 0.03% 205
2021
Q4 		$218K Buy
+2,555
New +$200K 0.01% 321
2020
Q3 		– Sell
-377
Closed -$28K – 283
2020
Q2 		$28K Sell
377
-170
-31% -$12.1K ﹤0.01% 323
2020
Q1 		$36K Buy
547
+412
+305% +$29.1K ﹤0.01% 208
2019
Q4 		$9K Buy
135
+21
+18% +$1.43K ﹤0.01% 359
2019
Q3 		$8K Hold
114
– – ﹤0.01% 391
2019
Q2 		$8K Buy
+114
New +$8.09K ﹤0.01% 356
2018
Q1 		– Sell
-646
Closed -$49K – 147
2017
Q4 		$49K Sell
646
-250
-28% -$18.3K ﹤0.01% 275
2017
Q3 		$65K Buy
896
+250
+39% +$18K 0.01% 231
2017
Q2 		$48K Hold
646
– – ﹤0.01% 248
2017
Q1 		$47K Hold
646
– – ﹤0.01% 228
2016
Q4 		$42K Buy
646
+11
+2% +$754 ﹤0.01% 228
2016
Q3 		$47K Hold
635
– – 0.01% 168
2016
Q2 		$46K Buy
635
+445
+234% +$31.7K 0.01% 155
2016
Q1 		$13K Hold
190
– – ﹤0.01% 221
2015
Q4 		$13K Buy
+190
New +$12.6K ﹤0.01% 292

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Balentine LLC's CL Position: Q2 2024 in Review

Balentine LLC sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 14,865 shares — an estimated $1.34M sold.

Balentine LLC first reported a position in CL in Q4 2015 and held it in 24 quarters. The position peaked at $1.86M in Q4 2022. 1,822 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • Balentine LLC reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 14,865 Colgate-Palmolive shares in Q2 2024, an estimated $1.34M.
  • Balentine LLC first reported a position in Colgate-Palmolive in Q4 2015 and held it in 24 quarters.
  • Balentine LLC's Colgate-Palmolive position peaked at $1.86M in Q4 2022.
  • 1,822 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.